FDA Awaits More Effexor Data Following U.K. Regulatory Changes
FDA is awaiting further data on Wyeth's Effexor following U.K. regulatory changes for the antidepressant
FDA is awaiting further data on Wyeth's Effexor following U.K. regulatory changes for the antidepressant